Literature DB >> 31647327

Commentary on Engen et al: Risk-based, dynamic, process-oriented monitoring strategies and their burden.

Marnie Bertolet1, Maria Mori Brooks1, Jeffrey L Carson2.   

Abstract

Year:  2019        PMID： 31647327     DOI： 10.1177/1740774519881617

Source DB:  PubMed          Journal:  Clin Trials        ISSN： 1740-7745            Impact factor:   2.486


× No keyword cloud information.
  2 in total

1.  Central monitoring in a randomized, open-label, controlled phase 3 clinical trial for a treatment-shortening regimen for pulmonary tuberculosis.

Authors:  Kia E Bryant; Yan Yuan; Melissa Engle; Ekaterina V Kurbatova; Cynthia Allen-Blige; Kumar Batra; Nicole E Brown; Kuo Wei Chiu; Howard Davis; Mascha Elskamp; Melissa Fagley; Pamela Fedrick; Kimberley N C Hedges; Kim Narunsky; Joanita Nassali; Mimi Phan; Ha Phan; Anne E Purfield; Jessica N Ricaldi; Kathleen Robergeau-Hunt; William C Whitworth; Erin E Sizemore
Journal:  Contemp Clin Trials       Date:  2021-03-10       Impact factor: 2.226

2.  Assessing the potential for prevention or earlier detection of on-site monitoring findings from randomised controlled trials: Further analyses of findings from the prospective TEMPER triggered monitoring study.

Authors:  William J Cragg; Caroline Hurley; Victoria Yorke-Edwards; Sally P Stenning
Journal:  Clin Trials       Date:  2020-11-24       Impact factor: 2.486
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.